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Background
PFAPA syndrome is a periodic fever syndrome with diag-
nostic criteria including unspecific symptoms and exclu-
sion of other fever syndromes.
Aim and methods
To investigate the clinical spectre, clinical course and
long-term follow-up of PFAPA, we established a web-
based multicentric registry as an international collabora-
tion within the working party "periodic fevers" of PReS.
Patients with PFAPA were included according to previ-
ously published criteria.
Results
We included 214 patients from 14 centres: 122 males, 92
females, median age at onset 1.9 year. The main clinical
manifestations were present in a majority of the patients:
pharyngitis (94%), cervical adenitis (83%), aphtous sto-
matitis (59%); 48% of the patients presented all 3 clinical
features. 170 patients presented additional symptoms
(gastrointestinal symptoms 131, arthralgias and/or myal-
gias 86, arthritis 4, skin rash 36, neurological symptoms
8). In 79 patients a genetic testing was done for periodic
fever syndromes (FMF 49, TRAPS 52, HIDS 46, CAPS 7)
and was negative, except for 8 cases (polymorphisms: 3,
carrier for MEFV mutation: 5) without known clinical sig-
nificance. Improvement or remission was observed in 99/
105 patients with steroids, in 28/35 patients with tonsil-
lectomy and in 5/15 patients with cimetidine.
Discussion
We describe the largest cohort of PFAPA patients pre-
sented so far. We confirm that PFAPA syndrome may
present with varied clinical manifestations and that the
diagnostic criteria lack of precision. Based on detailed
analysis of this cohort, a new definition of PFAPA with
better-defined criteria should be discussed in an interna-
tional consensus conference.
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